STOCK TITAN

CARTESIAN GRTH CP II WTS 10-Q Filings

REEWF OTC

Every 10-Q that CARTESIAN GRTH CP II WTS (REEWF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow REEWF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full REEWF filings page.

Rhea-AI Summary

Cartesian Growth Corporation II, a Cayman Islands SPAC, reported for the quarter ended June 30, 2026. It has not begun operating activities and continues to seek a Business Combination. Total assets were $38.6 million, including $38.4 million in an interest-bearing Trust Account and $149,017 of cash outside the trust.

Total liabilities were $24.7 million, including warrant liabilities of $1.8 million, related-party convertible promissory notes at fair value of $5.2 million, and deferred underwriting fees of $11.5 million. Shareholders’ deficit was $(24.4 million), and 3,076,094 Class A ordinary shares were classified as subject to possible redemption at an aggregate redemption value of $38.4 million.

For the six months ended June 30, 2026, the company recorded net income of $2.4 million, driven mainly by a $2.7 million non-cash gain from changes in warrant fair value and $0.5 million of trust interest, partially offset by $0.8 million in general and administrative costs. The second quarter alone showed a net loss of $0.7 million. Management disclosed substantial doubt about the ability to continue as a going concern due to limited liquidity and a mandatory liquidation date of August 5, 2027 if no Business Combination closes.

The trust has been significantly reduced by multiple shareholder redemptions tied to charter extensions, and the company was delisted from Nasdaq in July 2025 and is now quoted on the over-the-counter market. On July 24, 2026, it entered into a Business Combination Agreement with InoBat AS valuing InoBat at $1.265 billion, subject to closing conditions.

Rhea-AI Summary

Cartesian Growth Corporation II reports unaudited results for the quarter ended March 31, 2026, as it continues to search for a business combination. Total assets were $38.4 million, including $38.1 million held in its trust account, and cash outside the trust was $105,287, reflecting tight liquidity.

The company recorded net income of $3.1 million, mainly from a $3.1 million non‑cash gain on warrant liabilities and $230,601 of interest on the trust, while general and administrative costs were $242,432. Class A ordinary shares subject to possible redemption totaled 3,076,094 at a redemption value of about $12.40 per share.

Management discloses substantial doubt about the company’s ability to continue as a going concern, given a working capital deficit of about $5.6 million and an August 5, 2026 deadline to complete a deal. The company has relied on multiple sponsor-backed promissory notes and extension payments, and its securities were delisted from Nasdaq in 2025 and are now quoted on the over‑the‑counter market.

Rhea-AI Summary

Cartesian Growth Corporation II (REEUF) filed its quarterly report. The SPAC reported cash and marketable securities in its Trust Account of $88,478,622 as of September 30, 2025, with cash of $44,123 outside the trust and a working capital deficit of $5,298,431. Net income was $338,160 for the quarter and $745,793 year-to-date, driven primarily by interest income on trust assets.

Shareholders redeemed 8,620,849 Class A shares for approximately $99,613,642 at $11.55 per share in connection with the November 2024 charter extension, leaving $83,770,196.61 in the Trust at that time. The company extended its combination deadline monthly to November 10, 2025 via sponsor-funded promissory notes, including $2.4 million available under a Second Extension Note, with $1.5 million of $250,000 monthly payments approved from May to October 2025.

Management disclosed “substantial doubt” about the company’s ability to continue as a going concern due to liquidity and the looming deadline. On July 15, 2025, its securities were delisted from Nasdaq and are now quoted on the OTC Pink. As of November 13, 2025, there were 8,826,092 Class A shares and two Class B shares outstanding.